Parameters of Lung Maturity During Late Pregnancy

January 24, 2020 updated by: Mahmoud Alalfy, Aljazeera Hospital

The Different Factors Involved in Fetal Maturity in Late Pregnancy

- Lung maturity is one of the most important factors in perinatal medicine

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

  • Fetal development passes in many stages till fetal maturation occurs
  • We are trying to line out fetal maturation

Study Type

Observational

Enrollment (Anticipated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Giza, Egypt
        • Not yet recruiting
        • Algazeerah and Kasralainy hospital
      • Giza, Egypt
        • Recruiting
        • Algazeerah and Kasralainy hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

22 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

pregnant ladies from 28 weeks till term

Description

Inclusion Criteria:

  • pregnant ladies from 28 weeks till term

Exclusion Criteria:

  • pregnant ladies before 28 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of fetuses who will be mature postnatally
Time Frame: within 2 weeks
the neonates who willnot need incubators
within 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Aljazeera Hospital

Collaborators

Kasr El Aini Hospital
National Research Centre, Egypt

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 12, 2018

Primary Completion (Anticipated)

July 15, 2020

Study Completion (Anticipated)

August 20, 2020

Study Registration Dates

First Submitted

November 3, 2018

First Submitted That Met QC Criteria

November 3, 2018

First Posted (Actual)

November 6, 2018

Study Record Updates

Last Update Posted (Actual)

January 27, 2020

Last Update Submitted That Met QC Criteria

January 24, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Lung

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Clinical Trials on Ultrasonography

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe